These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7461966)

  • 1. L-dopa effect on prolactin plasma levels in complicated and common migrainous patients.
    Vardi J; Flechter S; Ayalon D; Cordova T; Oberman Z
    Headache; 1981 Jan; 21(1):14-20. PubMed ID: 7461966
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Prolactin, levodopa, and migraine.
    Parantainen J
    Lancet; 1975 Feb; 1(7904):467. PubMed ID: 48666
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolactin and migraine: effect of L-dopa on plasma prolactin levels in migraineurs and normals.
    Nattero G; Corno M; Savi L; Isaia GC; Priolo C; Mussetta M
    Headache; 1986 Jan; 26(1):9-12. PubMed ID: 3781829
    [No Abstract]   [Full Text] [Related]  

  • 4. No evidence for a peripheral effect of L-DOPA on plasma prolactin in the rat.
    Mattheij JA; Brouwer GM; Hanstede JG; Swarts JJ
    Life Sci; 1982 Aug; 31(9):915-21. PubMed ID: 7176820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prolactin, a marker of essential headache?].
    Nattero G; Savi L; Isaia GC; Corno M; Priolo C; Mussetta M
    Minerva Med; 1987 Jul; 78(14):989-92. PubMed ID: 3601174
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Prolactin, levodopa, and migraine.
    Rozencweig M; Heuson JC
    Lancet; 1975 Apr; 1(7910):810. PubMed ID: 48041
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolactin inhibition test with L-dopa: decrease and restoration of plasma prolactin levels in the rat by a peripheral process.
    van der Gugten AA; Sahuleka PC; van Galen GH; Kwa HG
    J Endocrinol; 1976 Mar; 68(3):369-81. PubMed ID: 1255091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-Dopa inhibits prolactin secretion in proestrous rats.
    Wiggins JF; Fernstrom JD
    Endocrinology; 1977 Aug; 101(2):469-74. PubMed ID: 560295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberoinfundibular dopaminergic tonus in common migraine.
    Lara Capellan JI; Varela Dacosta C; Gutierrez Garcia JM; Riobo Servan P; Alvarez Cermeño JC
    Headache; 1990 Apr; 30(5):282-4. PubMed ID: 2354952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous diurnal variations of serum prolactin and prolactin response to L-dopa in man. Effect of cyproheptadine.
    Delitala G; Masala A; Alagna S; Rovasio PP; Devilla L
    IRCS J Med Sci; 1975 Apr; 3(4):199. PubMed ID: 1172495
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the effect of levodopa and somatostatin on the plasma levels of growth hormone, insulin, glucagon and prolactin in acromegaly.
    Dunn PJ; Donald RA; Espiner EA
    Clin Endocrinol (Oxf); 1976 Mar; 5(2):167-74. PubMed ID: 1269163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. l-deprenyl test in migraine: neuroendocrinological aspects.
    Calabresi P; Silvestrini M; Stratta F; Cupini LM; Argiro G; Atzei GP; Bernardi G
    Cephalalgia; 1993 Dec; 13(6):406-9. PubMed ID: 8313454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of haloperidol and L-dopa on plasma prolactin in stalk-sectioned and intact monkeys.
    Langer G; Ferin M; Sachar EJ
    Endocrinology; 1978 Feb; 102(2):367-70. PubMed ID: 105868
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of prolactin by dopamine agonists in schizophrenics and controls.
    Rotrosen J; Angrist B; Clark C; Gershon S; Halpers FS; Sachar EJ
    Am J Psychiatry; 1978 Aug; 135(8):949-51. PubMed ID: 665840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of carbidopa and L-dopa to suppress the prolactin stimulating effect of sulpiride in normal man.
    Zanoboni A; Zanoboni-Muciaccia W; Gattei G; Crespi R
    Farmaco Prat; 1980 Oct; 35(10):510-5. PubMed ID: 7449936
    [No Abstract]   [Full Text] [Related]  

  • 16. [L-dopa and prolactin in breast neoplasms and dysplasia].
    Moguilevsky L; Scacchi P; Szwarcfarb B; Barbarelli J; Moguilevsky JA
    Medicina (B Aires); 1978; 38(1):27-30. PubMed ID: 713825
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of low dose carbidopa/levodopa on prolactin and growth hormone concentrations in patients with breast cancer and in benign breast tumours.
    Jones MK; Ramsay ID; Jenner PG
    Br J Clin Pharmacol; 1978 May; 5(5):425-30. PubMed ID: 656281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma prolactin response to L-dopa TRH and metaclopramide in thyrotoxicosis.
    Delitala G; Masala A; Alagna S; Devilla L
    Biomedicine; 1976 Jul; 25(5):173-6. PubMed ID: 1000028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of prolactin secretion by L-dopa in the stalk-sectioned rhesus monkey.
    Diefenbach WP; Carmel PW; Frantz AG; Ferin M
    J Clin Endocrinol Metab; 1976 Sep; 43(3):638-42. PubMed ID: 821963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum prolactin and migraine.
    Masoud SA; Fakharian E
    Ann Saudi Med; 2005; 25(6):489-91. PubMed ID: 16438460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.